LEVITSKY; Hyam I.

Patent Applications and Registrations

Patent applications and USPTO patent grants for LEVITSKY; Hyam I..The latest application filed is for "mouse model for assessing toxicities associated with immunotherapies".

Company Profile

4.11.15

LEVITSKY; Hyam I. - Seattle WA
Levitsky; Hyam I. - Owing Hills MD US
LEVITSKY; Hyam I. - Owings Mills MD
Levitsky; Hyam I. - Owing Mills MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Mouse Model For Assessing Toxicities Associated With Immunotherapies App 20220225597 - CHADWICK; Eric Martin ; et al.	2022-07-21
Engineered Cells For Adoptive Cell Therapy App 20200384031 - MOHLER; Kendall M. ; et al.	2020-12-10
Engineered Cells For Adoptive Cell Therapy App 20200318070 - MOHLER; Kendall M. ; et al.	2020-10-08
Engineered cells for adoptive cell therapy Grant 10,786,533 - Mohler , et al. September 29, 2	2020-09-29
Methods Of Identifying Cellular Attributes Related To Outcomes Associated With Cell Therapy App 20200292526 - HAUSE, Jr.; Ronald James ; et al.	2020-09-17
Engineered cells for adoptive cell therapy Grant 10,738,278 - Mohler , et al. A	2020-08-11
Immunotherapy Methods And Compositions Involving Tryptophan Metabolic Pathway Modulators App 20200054673 - PORTS; Michael ; et al.	2020-02-20
Engineered B Cells And Related Compositions And Methods App 20190321403 - LEVITSKY; Hyam I.	2019-10-24
Combination Therapy Of A Cell Based Therapy And A Microglia Imhibitor App 20190292246 - LEVITSKY; Hyam I.	2019-09-26
Engineered Cells For Adoptive Cell Therapy App 20190201442 - MOHLER; Kendall M. ; et al.	2019-07-04
Engineered Cells For Adoptive Cell Therapy App 20170204372 - MOHLER; Kendall M. ; et al.	2017-07-20
Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine Grant 8,383,096 - Ambinder , et al. February 26, 2	2013-02-26
Universal GM-CSF Expressing Bystander Human Cell Line App 20110287058 - LEVITSKY; Hyam I. ; et al.	2011-11-24
Universal GM-CSF expressing bystander human K562 cell line Grant 8,012,469 - Levitsky , et al. September 6, 2	2011-09-06
Cancer Immunotherapy With A Viral Antigen-defined, Immunomodulator-secreting Cell Vaccine App 20100272760 - Ambinder; Richard F. ; et al.	2010-10-28
Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine Grant 7,740,871 - Ambinder , et al. June 22, 2	2010-06-22
Universal Gm-csf Expressing Bystander Human K562 Cell Line App 20080260758 - Levitsky; Hyam I. ; et al.	2008-10-23
Universal GM-CSF expressing bystander human K562 cell line Grant 7,390,483 - Levitsky , et al. June 24, 2	2008-06-24
Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine App 20060233770 - Ambinder; Richard F. ; et al.	2006-10-19
Universal GM-CSF expressing bystander human K562 cell line App 20060140922 - Levitsky; Hyam I. ; et al.	2006-06-29
Universal GM-CSF expressing bystander human K562 cell line Grant 6,464,973 - Levitsky , et al. October 15, 2	2002-10-15
Universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use App 20020037282 - Levitsky, Hyam I. ; et al.	2002-03-28
Method of treating cancer with a tumor cell line having modified cytokine expression Grant 6,350,445 - Jaffee , et al. February 26, 2	2002-02-26
Method of treating cancer with a tumor cell line having modified cytokine expression Grant 6,033,674 - Jaffee , et al. March 7, 2	2000-03-07
Purified pancreatic tumor cell lines and related compositions and method Grant 5,985,290 - Jaffee , et al. November 16, 1	1999-11-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.